0001932386-25-000003.txt : 20251016 0001932386-25-000003.hdr.sgml : 20251016 20251016093359 ACCESSION NUMBER: 0001932386-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251016 DATE AS OF CHANGE: 20251016 EFFECTIVENESS DATE: 20251016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SightStream Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001932386 ORGANIZATION NAME: EIN: 852434013 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-561030 FILM NUMBER: 251396642 BUSINESS ADDRESS: STREET 1: 55 WEST STREET, SUITE 201 CITY: WALPOLE STATE: MA ZIP: 02081 BUSINESS PHONE: 617-388-2635 MAIL ADDRESS: STREET 1: 55 WEST STREET, SUITE 201 CITY: WALPOLE STATE: MA ZIP: 02081 FORMER COMPANY: FORMER CONFORMED NAME: Kera Therapeutics, Inc. DATE OF NAME CHANGE: 20220603 D 1 primary_doc.xml X0708 D LIVE 0001932386 SightStream Biotherapeutics, Inc. 55 WEST STREET, SUITE 201 WALPOLE MA MASSACHUSETTS 02081 617-388-2635 DELAWARE Kera Therapeutics, Inc. Corporation true Jason Werner 55 West Street, Suite 201 Walpole MA MASSACHUSETTS 02081 Executive Officer Director Reza Dana 55 West Street, Suite 201 Walpole MA MASSACHUSETTS 02081 Director Samuel Wu 55 West Street, Suite 201 Walpole MA MASSACHUSETTS 02081 Director Wenkai Xiang 55 West Street, Suite 201 Walpole MA MASSACHUSETTS 02081 Director David Neafus 55 West Street, Suite 201 Walpole MA MASSACHUSETTS 02081 Executive Officer Biotechnology Decline to Disclose 06b false 2025-10-02 false true true true Simple Agreement for Future Equity false 0 1791165 1791165 0 false 9 0 0 0 false SightStream Biotherapeutics, Inc. /s/ Jason Werner Jason Werner President 2025-10-16